02 Apr 2019

FDA Takes New Enforcement Actions as Part of the Agency’s Ongoing Effort to Combat the Illegal Online Sales of Opioids

By David Arvelo

WASHINGTON DC (April 2, 2019) — Today the US Food and Drug Administration announced the issuance of two warning letters to operators of websites that illegally market potentially dangerous, unapproved, and misbranded opioid medications, including tramadol.

02 Apr 2019

FDA Commissioner Scott Gottlieb MD on New Steps to Advance Agency’s Continued Evaluation of Potential Regulatory Pathways for Cannabis-Containing and Cannabis-Derived Products

By David Arvelo

WASHINGTON DC (April 2, 2019) — In recent years, we’ve seen a growing interest in the development of therapies and other FDA-regulated consumer products derived from cannabis (Cannabis sativa L.) and its components, including cannabidiol (CBD). This interest spans the range of product categories that the agency regulates.

02 Apr 2019

Statement from FDA Commissioner Scott Gottlieb MD on the Agency’s Continued Efforts to Bring Competition to the Insulin Market to Lower Prices and Expand Access

By David Arvelo

WASHINGTON DC (April 2, 2019) — Access to affordable insulin can be a matter of life and death for Americans with diabetes. Insulin is a critical hormone that regulates sugar metabolism. The body’s inability to produce sufficient levels of natural insulin can lead to diabetes — both inherited Type 1 and Type 2, typically called adult-onset.

02 Apr 2019

Hy-Vee Providing Free A1C Screenings in April

By Christina Gayman

WEST DES MOINES, IOWA (April 2, 2019) — In honor of National Diabetes Awareness Month, Hy-Vee Inc is providing free Hemoglobin A1C screenings throughout its eight-state region during the month of April.

01 Apr 2019

FDA Warns Homeopathic Firms for Putting Patients at Risk with Significant Violations of Manufacturing Quality Standards

By David Arvelo

WASHINGTON DC (April 1, 2019) — The US Food and Drug Administration (USFDA) today posted warning letters to four companies who produce homeopathic drug-products for significant violations of current good manufacturing practice (CGMP) regulations, including a letter to King Bio Inc of Asheville, NC.

01 Apr 2019

American Medical Association (AMA), Leading Physician Organizations Defend Affordable Care Act Gains in New Texas v United States Court Filing

By American Medical Association

CHICAGO, ILLINOIS (April 1, 2019) — In defense of significant coverage gains and key patient protection provisions of the Affordable Care Act (ACA), the American Medical Association (AMA) and other leading physician organizations today filed an amicus brief in the case of Texas v United States.

30 Mar 2019

FDA Approves New Oral Treatment for Multiple Sclerosis

By David Arvelo

WASHINGTON DC (March 29, 2019) — The US Food and Drug Administration (USDA) today approved Mavenclad (cladribine) tablets to treat relapsing forms of multiple sclerosis (MS) in adults, to include relapsing-remitting disease and active secondary progressive disease. Mavenclad is not recommended for MS patients with clinically-isolated syndrome.

29 Mar 2019

FDA Approves Treatment for Patients with a Type of Inflammatory Arthritis

By David Arvelo

WASHINGTON DC (March 28, 2019) — The US Food and Drug Administration today approved Cimzia (certolizumab pegol) injections for treatment of adults with a certain type of inflammatory arthritis called non-radiographic axial spondyloarthritis (nr-axSpA) with objective signs of inflammation. This is the first time that the FDA has approved a treatment for nr-axSpA.

27 Mar 2019

Food and Drug Administration (FDA) Advances Landmark Policy-Changes to Modernize Mammography Services and Improve Their Quality

By David Arvelo

WASHINGTON DC (March 27, 2019) — Today, the US Food and Drug Administration (FDA) announced important new steps to modernize breast-cancer screening and help empower patients with more information when they are considering important decisions regarding their breast health care.

26 Mar 2019

Gilda’s Club 8-Week Mind, Body, Spirit Challenge in Muscatine

By Kelly Craft

MUSCATINE, IOWA (March 26, 2019) — Beginning in March 2019, Gilda’s Club Quad Cities launched an 8-Week Mind, Body, Spirit Challenge to help people diagnosed with cancer, including those undergoing treatment and caregivers, to improve quality of life by better managing the stress of diagnosis and treatment.

Pages

Subscribe & Listen to Reader Podcasts

On Stands Now

 

Tagged Content

    

Two Ways to Subscribe

1. Subscribe to free weekly e-mail content updates.

You'll get both the current official narrative challenge and What's Happenin' in the Quad Cities.
(Did you know we publish a new Real Astrology and RCR Crossword every week?) 

Subscribe!

* indicates required

2. Get 12 monthly issues mailed first class for $48

Get 12 issues mailed monthly for $48 per year.

Get the printed Reader edition mailed to you (or anyone you want) first-class for 12 months for $48.
$24 goes to postage and handling, $24 goes to keeping the doors open!

Click this link to Subscribe now.